LifeScience Clinical & Diagnostic
QIAGEN launches QIAstat-Dx Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, joining the Respiratory SARS-CoV-2 Panel QIAstat-Dx s...
February 06, 2024 | News
DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the comp...
February 04, 2024 | News
Lung cancer has a significant health and economic impact in the region. It is the most prevalent cancer, accounting for about 1 million deaths per year, an...
February 04, 2024 | News
Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have reported that the European Medicines Agency (EMA) has validated the marketing authorization app...
February 02, 2024 | News
Fast track is a process designed to facilitate development, and accelerate the review of drugs to treat serious or life-threatening conditions and fill an ...
February 02, 2024 | News
The value of the companion diagnostics market is predicted to expand to nearly US $14B by 2030, driven in part by the power of these tests to inform t...
February 01, 2024 | News
Treatment with VX-548 led to statistically significant improvement in pain compared to placebo as well as a clinically meaningful reduction in pain from ...
January 31, 2024 | News
Fresenius Kabi announced it has introduced Posaconazole Injection, a generic substitute for Noxafil®, for use in treating or preventing serious fungal ...
January 30, 2024 | News
NADclinic's Groundbreaking IV Protocols Now in the Middle East NADclinic Group is a revolutionary health and wellness organisation, specialising in the pr...
January 26, 2024 | News
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East ...
January 26, 2024 | News
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and e...
January 25, 2024 | News
"We are all delighted to see CBL-514 showing its potential to become the new, promising, non-invasive fat reduction treatment in the previous Pha...
January 24, 2024 | News
PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existin...
January 24, 2024 | Regulatory
Merck, a distinguished science and technology company, has announced groundbreaking real-world data that further solidify the JAVELIN Bladder regimen as a ...
January 23, 2024 | News
Most Read
Bio Jobs
News
Editor Picks